Search research articles
Contact Us
Filters
Showing results (481-490 of 552) with videos related to
Page
of 56
Sort By:
Science Immunology
|
October 11, 2024
Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8<sup>+</sup> T cells
Daniel Malouli, Husam Taher, Mandana Mansouri, et al.
ESMO Open
|
July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
D König, S Savic Prince, S Hayoz, et al.
Plos Pathogens
|
December 16, 2016
Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors
Iryna Dekhtiarenko, Robert B Ratts, Renata Blatnik, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 23, 2021
Identification and Characterization of Antigen-Specific CD8<sup>+</sup> T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing
Shaheed Abdulhaqq, Abigail B Ventura, Jason S Reed, et al.
The Lancet. Oncology
|
November 6, 2015
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
Rolf A Stahel, Oliver Riesterer, Alexandros Xyrafas, et al.
Plos One
|
January 24, 2019
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge
Scott G Hansen, Jennie Womack, Isabel Scholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2019
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer
Marcel P Trefny, Sacha I Rothschild, Franziska Uhlenbrock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 15, 2025
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial
E Felip, S Popat, U Dafni, et al.
International Journal of Environmental Research and Public Health
|
January 22, 2024
Unpacking the Public Health Triad of Social Inequality in Health, Health Literacy, and Quality of Life-A Scoping Review of Research Characteristics
Heidi Holmen, Tone Flølo, Christine Tørris, et al.
Science Advances
|
May 10, 2024
CD8<sup>+</sup> T cell targeting of tumor antigens presented by HLA-E
Ravi F Iyer, Marieke C Verweij, Sujit S Nair, et al.
Page
of 56
Search research articles
Search
Showing results (481-490 of 552) with videos related to
Sort By:
Page
of 56
Science Immunology
|
October 11, 2024
Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8<sup>+</sup> T cells
Daniel Malouli, Husam Taher, Mandana Mansouri, et al.
ESMO Open
|
July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
D König, S Savic Prince, S Hayoz, et al.
Plos Pathogens
|
December 16, 2016
Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors
Iryna Dekhtiarenko, Robert B Ratts, Renata Blatnik, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 23, 2021
Identification and Characterization of Antigen-Specific CD8<sup>+</sup> T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing
Shaheed Abdulhaqq, Abigail B Ventura, Jason S Reed, et al.
The Lancet. Oncology
|
November 6, 2015
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
Rolf A Stahel, Oliver Riesterer, Alexandros Xyrafas, et al.
Plos One
|
January 24, 2019
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge
Scott G Hansen, Jennie Womack, Isabel Scholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2019
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer
Marcel P Trefny, Sacha I Rothschild, Franziska Uhlenbrock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 15, 2025
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial
E Felip, S Popat, U Dafni, et al.
International Journal of Environmental Research and Public Health
|
January 22, 2024
Unpacking the Public Health Triad of Social Inequality in Health, Health Literacy, and Quality of Life-A Scoping Review of Research Characteristics
Heidi Holmen, Tone Flølo, Christine Tørris, et al.
Science Advances
|
May 10, 2024
CD8<sup>+</sup> T cell targeting of tumor antigens presented by HLA-E
Ravi F Iyer, Marieke C Verweij, Sujit S Nair, et al.
Page
of 56